Session » Abstracts: Patient Outcomes, Preferences, & Attitudes (1909–1914)
- 2:00PM-2:15PM
-
Abstract Number: 1909
Impact of Antimalarial Adherence on Cardiovascular Mortality Among Patients with Newly Diagnosed Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population-based Study
- 2:15PM-2:30PM
-
Abstract Number: 1910
Association Between Clinically Meaningful Improvements in Patient-Reported Outcomes and Stringent Measures of Disease Activity in Patients with Psoriatic Arthritis Treated with Upadacitinib versus Placebo or Adalimumab: Results from a Phase 3 Trial
- 2:30PM-2:45PM
-
Abstract Number: 1911
Patient’s and Rheumatologist’s Perspectives on the Burden of Adverse Drug Reactions Attributed to Biologics: A Qualitative Study
- 2:45PM-3:00PM
-
Abstract Number: 1912
Meteorological Variables Have Different Effect on Core Measures of Disease Activity in Patients with Rheumatoid Arthritis
- 3:00PM-3:15PM
-
Abstract Number: 1913
Patient Perceptions of Telemedicine Use in Rheumatology Clinics During the COVID-19 Pandemic: An Analysis from the COVID-19 Global Rheumatology Alliance
- 3:15PM-3:30PM
-
Abstract Number: 1914
Immunomodulatory and Immunosuppressive Medication Modification Among Rheumatology Patients at the Time of COVID-19 Vaccination